We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-5.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.62B
AUM Growth
-$2.78B
Cap. Flow
-$2.47B
Cap. Flow %
-43.88%
Top 10 Hldgs %
56.27%
Holding
465
New
101
Increased
59
Reduced
84
Closed
204

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$44.1M
2
HRMY icon
Harmony Biosciences
HRMY
+$36.9M
3
TVTX icon
Travere Therapeutics
TVTX
+$33.9M
4
MDLN
Medline Inc
MDLN
+$22.4M
5
META icon
Meta Platforms (Facebook)
META
+$20.9M

Top Sells

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$70.6M
2
IMVT icon
Immunovant
IMVT
+$56.5M
3
XRAY icon
Dentsply Sirona
XRAY
+$53.6M
4
GEHC icon
GE HealthCare
GEHC
+$53.1M
5
PTCT icon
PTC Therapeutics
PTCT
+$51.5M

Sector Composition

Rank Sector Weight
1 Healthcare 38.27%
2 Technology 7.29%
3 Consumer Discretionary 4.25%
4 Communication Services 1.58%
5 Consumer Staples 1.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMH icon
276
American Homes 4 Rent
AMH
$12.1B
– –
-28,483
Closed -$914K
ANY icon
277
Sphere 3D
ANY
$12.2M
– –
-156,207
Closed -$465K
ARGX icon
278
argenx
ARGX
$52.9B
– –
-58,000
Closed -$48.8M
ARIS
279
Aris Mining
ARIS
$2.86B
– –
-18,210
Closed -$296K
AVB icon
280
AvalonBay Communities
AVB
$27.3B
– –
-1,638
Closed -$297K
AXS icon
281
AXIS Capital
AXS
$8.48B
– –
-3,169
Closed -$339K
AZO icon
282
AutoZone
AZO
$48.9B
– –
-321
Closed -$1.09M
BG icon
283
Bunge Global
BG
$23.4B
– –
-3,356
Closed -$299K
BJDX icon
284
Bluejay Diagnostics
BJDX
$1.25M
– –
-16,250
Closed -$43.4K
BKD icon
285
Brookdale Senior Living
BKD
$3.57B
– –
-13,977
Closed -$151K
BLCO icon
286
Bausch + Lomb
BLCO
$5.7B
– –
-18,944
Closed -$324K
BN icon
287
Brookfield
BN
$104B
– –
-17,686
Closed -$812K
BRBR icon
288
BellRing Brands
BRBR
$1.41B
– –
-85,521
Closed -$2.29M
BRO icon
289
Brown & Brown
BRO
$23.4B
– –
-2,590
Closed -$206K
BSX icon
290
Boston Scientific
BSX
$65.1B
– –
-114,025
Closed -$10.9M
BX icon
291
Blackstone
BX
$151B
– –
-1,789
Closed -$276K
BXSL icon
292
Blackstone Secured Lending
BXSL
$5.46B
– –
-11,412
Closed -$300K
CALX icon
293
Calix
CALX
$2.45B
– –
-5,537
Closed -$293K
CDTX
294
DELISTED
Cidara Therapeutics
CDTX
– –
-1,359
Closed -$300K
CDW icon
295
CDW
CDW
$16.6B
– –
-2,746
Closed -$374K
CE icon
296
Celanese
CE
$4.89B
– –
-22,945
Closed -$970K
CELH icon
297
Celsius Holdings
CELH
$7.52B
– –
-39,664
Closed -$1.81M
CGAU
298
Centerra Gold
CGAU
$3.02B
– –
-10,301
Closed -$148K
CGNX icon
299
Cognex
CGNX
$10.5B
– –
-8,242
Closed -$297K
CHTR icon
300
Charter Communications
CHTR
$15.9B
– –
-1,309
Closed -$273K
10 11
12
13 14

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Armistice Capital held 465 positions worth $5.62B, down 33% from $8.4B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital withdrew a net $2.47B in Q1 2026, closing 204 positions and reducing 84 holdings. Its most notable exit was argenx, an estimated $48.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Armistice Capital opened a new position in UnitedHealth worth $40M.

  • Armistice Capital's largest Q1 2026 buy was UnitedHealth: 148,000 shares worth $40M.
  • Armistice Capital added most to Harmony Biosciences in Q1 2026, an estimated $36.9M increase.
  • Armistice Capital's biggest Q1 2026 reduction was Kenvue, cutting an estimated $70.6M.
  • Armistice Capital fully exited argenx in Q1 2026, selling an estimated $48.8M.
  • Armistice Capital's ten largest holdings make up 56% of its $5.62B portfolio in Q1 2026.
  • Armistice Capital opened 101 new positions and closed 204 in Q1 2026.
  • Armistice Capital's portfolio value fell 33% quarter-over-quarter to $5.62B.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.